B
BridgeBio Oncology Therapeutics, Inc. (BBOT)
NGM – Real vaqt narxi. Valyuta: USD
8.13
+0.24 (3.04%)
Yopilishda: May 12, 2026, 4:00 PM EDT
7.92
-0.21 (-2.58%)
Bozor oldidan: May 13, 2026, 4:00 AM EDT
Find any stock by ticker or company name

NGM – Real vaqt narxi. Valyuta: USD
8.13
+0.24 (3.04%)
Yopilishda: May 12, 2026, 4:00 PM EDT
7.92
-0.21 (-2.58%)
Bozor oldidan: May 13, 2026, 4:00 AM EDT
This stock has a consensus price target of $24.00 based on the ratings of 7 analysts. The high is $29.00 and the low is $20.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 20 | $ 24 | $ 29 |
| O’zgarish | 161.10% | 213.32% | 278.59% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-06 | 278.59% | HC Wainwright & Co. | $27 → $29 | Maintains | Buy |
| 2026-02-11 | 200.26% | Stifel | $23 | Initiates Coverage On | Buy |
| 2026-01-09 | 213.32% | Raymond James | $24 | Initiates Coverage On | Outperform |
| 2025-12-11 | 226.37% | Wedbush | $25 → $25 | Reiterates | Outperform |
| 2025-12-05 | 161.1% | Morgan Stanley | $20 | Initiates Coverage On | Overweight |